Author Correction: ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target

被引：0
|
作者：
Dongli Liu
Kate Gunther
Luis A. Enriquez
Benjamin Daniels
Tracy A. O’Mara
Katrina Tang
Amanda B. Spurdle
Caroline E. Ford
机构：
[1] University of New South Wales,Gynaecological Cancer Research Group, Lowy Cancer Research Centre, School of Women’s and Children’s Health, Faculty of Medicine
[2] University of New South Wales,Medicines Policy Research Unit, Centre for Big Data Research in Health, Faculty of Medicine
[3] QIMR Berghofer Medical Research Institute,South Eastern Area Laboratory Services Pathology
[4] Prince of Wales Hospital,undefined
来源：
Scientific Reports | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
    Liu, Dongli
    Gunther, Kate
    Enriquez, Luis A.
    Daniels, Benjamin
    O'Mara, Tracy A.
    Tang, Katrina
    Spurdle, Amanda B.
    Ford, Caroline E.
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [2] ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
    Dongli Liu
    Kate Gunther
    Luis A. Enriquez
    Benjamin Daniels
    Tracy A. O’Mara
    Katrina Tang
    Amanda B. Spurdle
    Caroline E. Ford
    [J]. Scientific Reports, 10
  • [3] ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target (vol 9, 13906, 2020)
    Liu, Dongli
    Gunther, Kate
    Enriquez, Luis A.
    Daniels, Benjamin
    O'Mara, Tracy A.
    Tang, Katrina
    Spurdle, Amanda B.
    Ford, Caroline E.
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [4] ROR1: A novel target in endometrial cancer
    Liu, Dongli
    Gunther, Kate
    Daniels, Benjamin
    O'Mara, Tracy
    Tang, Katrina
    Ford, Caroline
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [5] ROR1 promotes the proliferation of endometrial cancer cells
    Zhang, Huilin
    Yan, Xiaofang
    Ke, Jieqi
    Zhang, Yongli
    Dai, Chenyun
    Zhu, Mei
    Jiang, Feizhou
    Wan, Xiaoping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (10): : 10603 - 10610
  • [6] Acid ceramidase is upregulated in AML and represents a novel therapeutic target
    Tan, Su-Fern
    Liu, Xin
    Fox, Todd E.
    Barth, Brian M.
    Sharma, Arati
    Turner, Stephen D.
    Awwad, Andy
    Dewey, Alden
    Doi, Kenichiro
    Spitzer, Barbara
    Shah, Mithun Vinod
    Morad, Samy A. F.
    Desai, Dhimant
    Amin, Shantu
    Zhu, Junjia
    Liao, Jason
    Yun, Jong
    Kester, Mark
    Claxton, David F.
    Wang, Hong-Gang
    Cabot, Myles C.
    Schuchman, Edward H.
    Levine, Ross L.
    Feith, David J.
    Loughran, Thomas P., Jr.
    [J]. ONCOTARGET, 2016, 7 (50) : 83208 - 83222
  • [7] ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
    Henry, C. E.
    Llamosas, E.
    Daniels, B.
    Coopes, A.
    Tang, K.
    Ford, C. E.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 576 - 584
  • [8] The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells
    Lee, Kyung-Jun
    Kim, Nam-Hyeok
    Kim, Hyeong Su
    Kim, Youngmi
    Lee, Jae-Jun
    Kim, Jung Han
    Cho, Hye-Yon
    Jeong, Soo Young
    Park, Sung Taek
    [J]. MEDICINA-LITHUANIA, 2023, 59 (05):
  • [9] Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
    Zhao, Yuming
    Zhang, Dengyang
    Guo, Yao
    Lu, Bo
    Zhao, Zhizhuang Joe
    Xu, Xiaojun
    Chen, Yun
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Evaluating ROR1 As a Target in Childhood Leukemia
    Diamanti, Paraskevi
    Bailey, Bethan Kathleen
    Iheanacho, Obinna Ebere
    Nathwani, Amit C.
    Blair, Allison
    [J]. BLOOD, 2019, 134
12345